Jefferies Assumes Prometheus Biosciences Inc (RXDX) at 'Buy', PT Raised to $160
Tweet Send to a Friend
(Updated - February 24, 2023 9:18 AM EST)
Jefferies analyst Michael Yee assumed coverage on Prometheus Biosciences Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Michael Yee assumed coverage on Prometheus Biosciences Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
